New Integrated Registry Platform to Transform Cardiovascular Research

A newly developed integrated registry platform, embedded within electronic medical records (EMR), is set to revolutionize cardiovascular and cerebrovascular research. This innovative system has successfully consolidated data across 27 specific modules, allowing for extensive real-world evidence generation and collection of patient-reported outcomes. The initiative aims to address the challenges posed by fragmented data systems in clinical settings.

The implementation of the cardiocerebrovascular registry spanned nine clinical areas, capturing a total of 2,890,478 cases from 396,481 patients between January 1, 2014, and May 31, 2026. The registry's design facilitates the integration of various cardiovascular and cerebrovascular conditions, enabling seamless data sharing and minimizing redundancy. A total of 61 medical experts, alongside data scientists and administrative staff, contributed to the project, ensuring a comprehensive approach to data collection and management.

The registry boasts 2,633 operational variables, including 329 common variables applicable across the modules. Data such as laboratory results, medications, and treatment histories were directly extracted from EMR systems, while clinical interpretations were entered through dedicated workflows. The quality assessments conducted during the implementation phase revealed high completeness across the evaluated disease areas, with mobile patient-reported outcomes being integrated into routine care. Notably, 58,315 questionnaires were administered to 23,537 unique individuals, resulting in a patient response rate of 48.8%, with the highest rates observed in new outpatient visits.

The platform also features cross-module event reuse, allowing confirmed clinical events to be shared across relevant disease registries. A consistency analysis showed a perfect concordance rate for selected event pairs, underscoring the reliability of the data. Governance structures were established through 19 dedicated meetings, focusing on quality control, data access, and long-term management strategies. The authors of the study concluded that the platform is not only feasible for routine clinical care but also holds potential for enhancing clinical monitoring, quality assessment, and observational research.

Looking ahead, further prospective evaluations will be necessary to assess the long-term sustainability, linkage completeness, and operational performance of the registry across its various modules. This integrated approach could pave the way for more effective patient-centered outcome studies and future investigations embedded within the registry framework.